Steinberg A D, Talal N
Clin Exp Immunol. 1970 Nov;7(5):687-91.
NZB/NZW mice with active lupus were treated with polyinosinic·polycytidylic acid, a synthetic double stranded RNA, followed by cyclophosphamide to induce immunologic tolerance to nucleic acids. This combined regimen reduced serum antibodies to RNA and DNA to a greater degree than did cyclophosphamide alone. This report demonstrates that a specific form of immunotherapy can be successfully employed to treat the serologic abnormalities of murine lupus.
对患有活动性狼疮的NZB/NZW小鼠,先用聚肌苷酸-聚胞苷酸(一种合成双链RNA)进行治疗,随后给予环磷酰胺以诱导对核酸的免疫耐受。与单独使用环磷酰胺相比,这种联合方案能更大程度地降低血清中针对RNA和DNA的抗体水平。本报告表明,一种特定形式的免疫疗法可成功用于治疗小鼠狼疮的血清学异常。